I-Brentuximab -Amayeza onyango lomhlaza
Umxholo
I-Brentuximab sisiyobisi esiboniswe kunyango lomhlaza, esinokusetyenziselwa ukunyanga i-Hodgkin's lymphoma, i-anaplastic lymphoma kunye nomhlaza weseli emhlophe.
Eli yeza arhente anti-umhlaza, iqulunqwe into emiselwe ukutshabalalisa iiseli zomhlaza, enxulunyaniswa iprotein eqonda iiseli ezithile zomhlaza (monoclonal antibody).
Ixabiso
Ixabiso le-Brentuximab liyahluka phakathi kwe-17,300 kunye ne-19,200 reais kwaye inokuthengwa kwiikhemesti okanye kwiivenkile ezikwi-Intanethi.
Indlela yokuthatha
Ngaphantsi kwengcebiso yezonyango, idosi yokuqala esetyenzisiweyo yi-1.8 mg kuyo yonke i-1 kg yobunzima, rhoqo kwiiveki ezi-3, ixesha elininzi leenyanga ezili-12. Ukuba kukho imfuneko kwaye ngokweengcebiso zonyango, le dosi ingancitshiswa iye kwi-1.2 mg ngekhilogram nganye yobunzima.
I-Brentuximab sisiyobisi esifakwa emithanjeni, ekufuneka silawulwe kuphela ngugqirha oqeqeshiweyo, umongikazi okanye ingcali yezempilo.
Imiphumela
Ezinye zeziphumo ebezingalindelekanga zeBrentuximab zinokubandakanya ukuphefumla okufutshane, umkhuhlane, usulelo, ukurhawuzelela, isikhumba somqala, iintlungu zomqolo, isicaphucaphu, ukuphefumla nzima, ukuncipha kweenwele, ukuziva uxinekile esifubeni, ukuncipha kweenwele, iintlungu zemisipha okanye utshintsha iziphumo zovavanyo lwegazi.
Ukungqinelana
I-Brentuximab iyaphikiswa kubantwana, abaguli abafumana unyango lwe-bleomycin kunye nezigulana ezinezigulo ezithile emzimbeni nakweliphi na icandelo lefomula.
Ukongeza, ukuba ukhulelwe okanye uncelisa okanye ukuba unayo nayiphi na ingxaki yezempilo, kuya kufuneka uthethe nogqirha wakho ngaphambi kokuba uqale unyango.